The effects of OGF on epithelial outgrowth were blacked by concomitant expasure ta the opioid antagonist naloxone; naloxone alone had no effect on growth at the concentration utilized. NTX and OGF were active in both serum-containing and serum-free cultures. Immunocytochemical investigations showed that both OGF and its opioid receptor zeta (0 were present in epithelial cells growing in control media. The results indicate that an endogenous opioid peptide and its receptor are present in mammalian corneal epithelium and serve to modulate cell proliferation, migration, and organization.
homeostatic renewal and repair of the corneal epithelium, epithelial outgrowths [rom 3-mm explants of rabbit cornea were investigated.
Blockade of opioid-receptor interaction by the potent opioid antagonist naltrexone (NTX) for 7 days significantly increased the extent of outgrowths and the number and labeling index (DNA synthesis) of epithelial cells, relative to contral levels. Outgrowths exposed to the opioid growth factar (OGF) [Met5]enkephalin for 7 days were subnormal in extent and labeling index and displayed alterations in architectural pattern.
The effects of OGF on epithelial outgrowth were blacked by concomitant expasure ta the opioid antagonist naloxone; naloxone alone had no effect on growth at the concentration utilized. NTX and OGF were active in both serum-containing and serum-free cultures. Immunocytochemical investigations showed that both OGF and its opioid receptor zeta (0 were present in epithelial cells growing in control media. The results indicate that an endogenous opioid peptide and its receptor are present in mammalian corneal epithelium and serve to modulate cell proliferation, migration, and organization.
[MetS]enkephalin; receptors; cell proliferation; cell migration; growth regulation; opioid antagonist; eye; visual system; wound healing; naltrexone THE CORNEAL EPITHELIUM contributes to maintaining the optical clarity of the cornea and provides a major protective barrier for the underlying cornea (8). The complete reepithelialization of the cornea after trauma or surgery is essential for the restitution of normal visual function (11) . Thus knowledge about the maintenance and repair of the corneal epithelium is extremely important. The role of growth factors in maintaining normal structure and function of the cornea, and in the healing of the corneal epithelium, has emerged in the past few years (17, 20) . A number of growth factors and/or receptors have been identified in corneal epithelium and their gene expression detected (6, 7, 10, 15-17, 20, 23--25) , but understanding about their role in cornea! biology in health and disease remains incomplete.
Endogenous opioids and receptors were originally thought to be related to neural modulation (1), but it is now clear that opioid peptides act as growth regulators in many normal and malignant tissues (28, 30 ). An opioid growth factor (OGF), the pentapeptide [Met'Jenkephalin, has been identified in both eukaryotes and prokaryotes as a potent inhibitor of cell replication
R942
(28-30, 33). In vertebrates, OGF is also thought to be important in cellular maturation and survival (13, 30) . OGF has been documented to be produced in an auto, crine, and probably paracrine, manner (27) . OGF activ' ity is mediated by the zeta m-opioid receptor (30, 31). Endogenous opioid systems (i.e., opioid peptides and receptors) influence proliferation in a wide variety of cells and tissues in vivo and in vitra, developing neurons and glia of the mammalian nervous system (including the retina), glial cells in culture, myocardial and epicardial cells in the neonatal heart, neural and nonneural cancer ceHs, and ceHular renewal in the epithelium of adult tongue (12, (28) (29) (30) 33) .
In this report the role of endogenous opioid systems in mammalian corneal epithelium was explored. A tissue culture system consisting of full thickness rabbit corneal explants fra m which Descemet's membrane and endothelium have been removed was utilized. The strat-·· egy employed in these experiments was to block opioip eptide-opioid receptor interaction with the potent and long-acting opioid antagonist naltrexone (NTX) to exam' ine wh ether this disruption modulates epithelial out1 growth as determined by morphometry and DNA synthe-, ,sis. In a subsequent set ofstudies, OGF was administered, to cultures of cornea! explants to investigate the effects of this opioid peptide on the extent and organization öẽ pithelial outgrowths, on DNA synthesis as monitore4 by [3HJthymidine incorporation, and on the receptorm edia ted nature of its effect. The dependence of opioid activity relative to corneal epithelial outgrowth on se! rum or stroma also was addressed. Finally, immunocytg: chemistry using antibodies specific to OGF and thopioid receptor was performed to determine whether, the components of an opioid peptide-opioid receptO system devoted to growth were present in norma corneal epithelium in culture. The results of this stud.
show that an endogenous opioid system is present in t~~:
outgrowths of corneal epithelium and exerts a profounĩ nf1uence on cell proliferation, migration, and patter!i formation. College of Medicine. Animals were killed~ã n overdose ofpentobarbital sodium; eyes were proptosed anẽ nucleated.
MATERIALS AND METHODS

Corneal explants.
Endotheliurn-free explants were prepared und.e: sterile conditions using a modification of earlier procedur~· '1 0363-6119/95 $3.00 Copyright.::: 1995 the American Physiological Society 15,l: In brief, Descemet's membrane and attached endothelium \\fere removed. Explants (3~m diameteri that penetrated the fuU thickness of the cor!1ea, consi:::.ting of epithelium and subjacent stroma in the peripheral (paracentral) cornea, were made using disposable trephines and spring scissors (5). Explants were positioned in the center of 22-mm round cover glasses in 35-mm tissue culture dishes with the epithelial surface placed up. Medium Onc1uding drugs) was added after _ 15 min, during which time explants became attached to the U1-· .. rlying coverslips. Explants were grown in RPMI-1640 ,( '.;0, Grand Island, NY) medium supplemented with 10% fet";l calf serum, 1.5% sodium bicarbonate, penicillin (18 V/mD, and streptomycin (12 µg); for some experiments, specimens were grown in the same medium without 10% fetal ealf serum. Cultures were grown at 37°C in a humidified atffiosphere of 7% CO2-93% air. Explants that did not adhere to the coverglass within 12 h were not utilized.
Opioid treatment. In the first set of experiments NTX, a long-acting and potent opioid antagonist that blocks the opioid n'(·(>ptor (2, 14), was added daily to the cultures for 7 days to ··mine whether opioid peptides influenced explant outth. NTX was utilized at a concentration of 10-6 M, wrnch or an equivalent volume 00 µ.l/ml of media) of sterile water (vehicle); media and drugs were changed daily.
In a second set ofexperiments, the effects ofOGF on corneal epithelial explant outgrowth were studied. Cultures were treated with 10-6 M OGF or an equal volume of sterile water " ,'hicle). In addition, to determine whether opioid action Irred at the level ofthe opioid receptor, some cultures were .:!ted concomitantly with 10-6 M OGF admixed with the short-acting opioid antagonist (2) naloxone (10-6 M). FinalIy, some explants were subjected to 10-6 M naloxone to assess whether this drug had any intrinsic effect on cell growth when used at a dosage and regimen described previously. Media and drugs were changed daily for 7 days. These drug concentrations were based on previous tissue culture experiments with neural and nonneural cells (28) ' Morphometric analysis, cell concentration, and cell cantent. '1;er7 days in culture (a time selected because a11outgrowths ·re still within the boundaries of the eoverslip) explants were ;lxed in 10% neutral buffered Formalin and stained with hematoxylin and eosin. Outgrowths were projected onto drawing paper, and the perimeter of specific regions (see RESULTS) was traced using a Jandel Scientific digitizing tablet and SigmaScan software (Jandel Scientific, Sausalito, CA). Areas and widths ofthe outgrowths were digitized and analyzed.
Cell concentration was determined at x400 using an oeular grid (0.01 mm2). At least 10 grids per outgrowth and 10 or 'lore corneal epithelial outgrowths were examined for each '-,atment regimen. Cell content was assessed by multiplying ·11concentration by area measurements.
Labeling indexes. In so me cases, [3H]thymidine (2 µCi/ml; specific activity 20 Ci/mrnol; DuPont-New England Nuclear, Boston, MA) was added to cultures 1 h before fixation after 7 days in culture. The cover glasses were processed for auto radiography using Kodak NTB-2 emulsion, developed in D-19, and counterstained with hematoxylin and eosin. The labeling index was computed by dividing the number of cells with grains three tirnes above background by the total number of I~ells; a total of at least 2,000 cells was investigated from 10 or more outgrowths per treatment.
Morphalogy and immunocytochemistry.
Cultures were exam· ined daily using phase contrast optics. Autoradiographie preparations were inspected and photographed with bright-field and R943 phase contrast objectives. Some unstained specimens were observed and photographed with phase contrast or Nomarski optics.
Ta ascertain the nature of the outgrowths in terms of cell typ:--(s), 7-day explant cultures were processed with pooled monoclonal antibodies to keratins (20:1 mixture of AE-l to AE-3). These antibodies were initially characterized by Tseng et al. (22) Statistical analysis. Data were analyzed using analysis of variance, and subsequent comparisons were made using Newman-Keuls tests.
RESULTS
Corneal epithelial outgrowth.
Morphological observatiOIlS of outgrowths using bright-field and phase contrast objectives (for stained preparations), and phase contrast and Nomarski optics (for unstained preparations) were performed on the 7th day in culture. The explant is defined as the original corneal tissue, whereas the outgrowth refers to cells that have migrated from the explant. Outgrowths of untreated rabbit corneal epithelium growing in tissue culture displayed a specific architectural pattern. Three distinct zones of outgrowth surrounded the explant (Figs. 1 and 2); beginning from the edge ofthe explant, these were named zones 1, 2, and 3. Zone 1 consisted of polygonal-shaped cells thatgenerally appeared to be tightly apposed to one another ( Fig.  2A ). These cells had round nuc1ei of moderate density with two to four heterochromatin clumps, few cellular processes, and were up~o 300 µm in diameter. Cells in this region appeared to be undergoing cell division because both mitotic and radiolabeled (i.e., [3Hlthymi-dine) cells were visible. Zone 2 was distinguished by the absence of [3Hlthymidine uptake or mitotically active cells (Fig. 2D) . This zone consisted ofcells that were less densely packed, had more cytoplasm and cellular processes than cells in zone 1, and were generally smaller in size than those in zone 1. The nuc1ei of cells in zone 2 were round, had two to four heterochromatin granules, and often appeared to be slightly less opaque than the nuclei of cells in zone 1. Zone 3 was characterized by rather large, irregularly shaped cells that often had one or tWD long processes and considerable space between cellular elements (Fig. 2G) . These cells were actively undergoing cell division because grains of radiolabeled thymidine and mitotic figures were recorded. Occasionally, smaller cells that assumed a variety of shapes, had a clear oval nucleus, and were extremely basophilic were noted in zones 1 and 2 ( Fig. 2A) . Cells in zone 3 had considerably more cytoplasm and smaller and less distinct nuclei than those in zones 1 and 2. In zones 1 and 2 some cells (or portions of cells) appeared to be stratified (see Figs. 2, 3, and 8) . Finally, all cells (including the smaller basophilic cells) in each of the three zones were reactive with antibodies to keratin (i.e., AE-1/AE-3); no staining was observed in preparations processed only with the secondary antibody (Fig. 3) . To verify the specificity of the pooled antibodies to epithelial cells, sections of human cornea and skin and rabbit cornea were stained; immunoreactivity was detected in the epithelium but not in the stroma (data not shown).
Because stroma was included in preparing the explant cultures, we made a careful evaluation of the possible presence of stromal cells (i.e., keratocytes; both active and quiescent) in the outgrowths at 7 days in culture. Fibroblast-like cells (i.e., thin and elongated spindleshaped profiles with an oval to oblong nucleus surrounded by scanty cytoplasm; Ref. 21) were not recorded in the outgrowths using bright-field, phase contrast, or Nomarski optics. Furthermore, explants in which the epithelial cells, Descemet's membrane, and endothelial cells were removed and the stroma placed in culture did not reveal any outgrowth for up to 2 wk (after which time experiments were terminated), confirming that fibroblasts would be unlikely to contaminate outgrowths within the 7-day course ofthis study. Finally, as mentioned earlier, all of the outgrowth cells stained with antibodies to AE-1/AE-3, indicating that a11 of the cellular elements in the outgrowths contained these keratins. Keratin is known to be present in the cytoplasm of epithelial cells but absent in keratocytes (22, 26).
Preliminary experiments were conducted in which the corneal explants were removed 2 days after cultures were initiated. Examination after 7 days in culturediscJosed a pattern of outgrowth similar to that observed when the explants were left in culture, suggesting that ." the contribution from the explant after day 2 is not of significance to the size or viability ofthe outgrowths.
Opioid antagonists and corneal epithelial outgrowth. No difference in the area ofthe explants between control -' and opioid antagonist-treated groups was recorded (Fig.  4B) . The morphology of outgrowth in zones 1,2, and 3 in the NTX-treated cultures was similar to controls except for differences in radiolabeled thymidine incorporation " (Fig. 2, B, E, and H) . The total area of outgrowth ofj NTX-treated corneal epithelial explants was 1390/~g reater than contrals after 7 days in culture (Fig. 4A) :" The area of zone 1 in outgrowths from explants sub-.j jected to NTX did not differ from controls, but zone 2j was nearly twice the area of control values and zone 3.'· was almost 5.6-fold greater than controllevels (Fig. 4B) . L Analysis of the width of each zone indicated that out,-.) growths receiving NTX did not differ from controls as to .z one 1, but the widths of zones 2 and 3 of the NTX:'ẽ xposed group were 2.3-to 2.5-fold greater than controls (  Fig. 4C) . The radius of the explants in control and! NTX-exposed cultures was equivalent (Fig. 4C) . Thec oncentration of cells in zones 1 and 3 of the NTXQ! treated outgrowths was comparable to controls, but .a,2 5% decrease from control values was noted in zone 2 o.~~: the NTX group (Fig. 5A) . The cellular content of eaclj" zone, as determined by multiplying the cell concentra;, tion by area, revealed no change from control levels iJ' zone 2, but zone 1 had 53% more cells and zone 3 had:a 6.5-fold increase in cell number in the NTX group (Figij 5B). Evaluation of the labeling index in outgrowtf rom explants subjected to NTX showed no change from' controls in zone 1, but zone 3 had an increase of 1250/6' from controllevels (Fig. 5C ).
iR Preliminary experiments were conducted in which tlj5 corneal explants were rernoved after 2 days in cultur:~t hese corneas continued to receive NTX after removal of the explant. Examination after 7 days in culture r4 vealed a pattern of accelerated outgrowth !TI the NTX\ treated specimens similar to that described earlier whe"U. the explant remained in the culture dish, suggestmg that the presence of the original' explant epitheliumã nd/or stroma was not necessary for NTX action.~* OGF and corneal epithelial outgrowth. Cultures eXJ posed to OG F lacked the distinctive boundaries of th.,e. zones described for the outgrowths in the control group (Figs. 1 and 2 ). The region of outgrowth adjacent to tbẽ xplant in the OGF-treated cultures contained polygona1s haped cells, with some cells in this zone undergoing DNA synthesis (Fig. 2C) . Cells midway between th1. edge of the explant and the most distal boundary of the outgrowth were polygonal shaped and less densely pack;;;! than those closest to the explant. groups from each other or from controls (Fig. 6A) . The total area of corneal epithelial outgrowth of the OGF '~oup, however, was decreased by 60% from contral 'vels, whereas the OGF-Nal and Nal groups were omparable to controls (Fig. 6A) . Evaluation of cell concentration and cell content in the OGF-treated cultu res was not possible because these outgrowths did not R947 have distinct zones. In contrast to the controls, thc labeling index of the distal boundary ofthe outgrowth ot OGF-treated cultures was decreased by 41%; the labeling indexes of thJ OGF-Nal and Nal groups were comparable to control values (Fig. 6B) .
To determine whether the presence of the explant was necessary for OGF action, experiments were conducted in which the buttons of cornea were removed after 2 days in culture; these corneas continued to receive OGF after rem oval of the explant. Examination after 7 days in culture revealed a pattern of outgrowth inhibition in the OGF-treated specimens comparable to that described earlier when the explant remained in the culture dish, suggesting that the presence ofthe original epithelium and/or stroma was not necessary for OGF action. Significantly different from controls at'" P < 0.05 or ** P < 0.01.
R94S OPIOlDS AND CORNEAL EPITHELIUM
Opioid antagonists, OGF, and corneal epithelial outgrowth in serum-free media. To evaluate whether the e!feets of OGF or NTX required serum, corneal epithelial explants were grown in serum-free media and subjected to these agents. Cultures grown in control serumfree media exhibited a total outgrowth area of 31.2 ± 1.3 mm' on day 7. In contrast, outgrowths of cultures exposed to NTX were increased hy 63%, and those receiving daily administration of OGF were decreased 30% (Fig. 7) . These data indicate that OGF and its antagonist NTX can alter corneal epithelial outgrowth independently of the presence of serum.
Localization of C-opioid receptor and OGF in corneal epithelial outgrowths. Antibodies to the t-opioid receptor revealed immunoreactivity associated with cornea! epithelial cells in 7-day explant preparations (Fig. S ) both in serum and serum-free culture conditions. The cortical cytoplasm of the epithelial cells was reactive to anti-t-receptor IgG. Although intense immunoreactivity sometimes was noted adjacent to the nucleus, staining ofthe nucleus was not observed (Fig. BA) . The intensity of immunoreactivity did appear to vary between some cells. There was DO immunoreactivity in contral specimens processed with antibody preabsorbed with antigen (Fig. SB) or in sampIes incubated with secondary antibody only (data not shown).
Examination of corneal explant outgrowths grown in culture for 7 days and stained with antibody to the OGF revealed a pattern of immunocytochemicallabeling similar to that obtained with the antibody to the t-receptor (Fig. S) ; staining was observed in both serum and serum-free cultures. OGF-like product was localized in the cytoplasm of corneal epithelial cells and was occasionally seen to be particularly rich near the nuclear envelope; cell nuclei were not stained (Fig. SD) . The intensity of OGF immunoreactivity sometimes varied from one ** '" '0 Fig. 7 . Effects of daily administration of NTX (10-6 M), OCF 00-6 M), or CO on rabbit cornea! epithelial explants grown for 7 days in serum-free media. Data represent means ::!:: SE of the relative outgrowth in area with respect to controls; control values were adjusted to 100'ft. Significantly different from controls at * P < 0.05 or u P < 0.01. cell to the other. Contral specimens pracessed wiã ntibody preabsorbed with antigen, or outgrowts tained with secondary antibody only, exhibited n!l, immunoreactivity (Fig. SE) .
DISCUSSION
The present study utilized explant cultures of rablill, corneal epithelium and followed procedures adap~. from earlier re ports (3, 5, 9, 15, 23). This weil! ;tablis..'led model is particularly suited to elucidating ,rocesses of cell migration, as weil as proliferation, lifferentiation, and cell-tissue formation, and has been Itili7.ed to investibate events associated with wound lealing_ Aspeetrum of cells in terms of size and shape vas noted_ This variety of cells in the outgrowths was Jrobably related to the fact that the cultures were not 'onfluent to permit examination of cell proliferation and ';ßl"ation. However, all of the cells in the outgrowths Itained keratin and, therefore, were epithelial in lilture. This report provides the first detailed descripion of the pattern of epithelial outgrowth, and based on ,orphology and the occurrence of DNA synthesis three cistinct zones of explant outgrowth were detected. The Örmation of outgrowths was not dependent on the Iresence ofthe explants, suggesting that neither trophic ',ctors nor cellular contributions from the explants '~re required for the maintenance ofthe outgrowths. It :lId be noted that neither a feeder layer (e.g., collagen ibroblasts) nor media supplemented with specific ruwth factors, as utilized in so me studies, were needed 3, 5, 9, 15, 23). In fact, in some experiments, the ultures grew in serum-free media, albeit slower than .ith serum-containing media. This finding would sugest that explant cultures of corneal epithelium growing 1 serum-free media may be used as a model to examine 1e effects of selective growth factors. The experiments in which the opioid antagonist NTX added to the cultures of corneal epithelial explants -ved that the extent and cellular content of the Jtgrowth, as weil as DNA synthesis, were markedly Icreased from controllevels. These data would suggest 1at explant outgrowth was modulated by the interacon of opioid peptides with opioid receptors because TX is an opioid antagonist that acts at the level of the oioid receptor. In addition, the interfacing ofOGF with opioid receptors must be quite active in the out-"ths because receptor hlockade produced a marked t. The influence of NTX also did not rely on the 'l'sence of serum, with opioid antagonist exposure aving considerable impact on outgrowths grown iñ rum-free media. Furthermore, these investigations Idicate that opioid peptides must be inhibitory to -owth because hlockade ofpeptide-receptor interaction imulated growth. These observations on corneal epithe-.Im are consistent with both in vivo and in vitra studies ,,·formed on a variety of other cells and tissues (12, '0, 33 Our experiments demonstrate that opioid action is hibitory to cellular proliferation. DNA synthesis was '!"'essed in cultures of corneal epithelial cells exposed '-;F, a result consistent with earlier reports in other and tissues (28) (29) (30) 33) . Not only was the size ofthe 'tgrowths in OGF-exposed cultures markedly diminhed from controls, but the pattern of outgrowth was disturbed in the presence of OGF. Thus OGF modulated ceUreplication and, for the first time, was shown to alter cell migration and the orchestration of cells into a specific architeeture. The effects of OGF on differentiation of outgrowths of corneal epithelium require elucidation. The present study also demonstrates that OGF activity is mediated by receptors because NaI, an opioid antagonist that is less potent and shorter-acting than NTX (2), blocked the effeets of OGF at a concentration that md not have any influence alone. Finally, this study reveals that the effects of OGF did not depend on the presence of serum, as OGF depressed growth in cultures of explants that were growing in serum-free media.
Ha\wg demonstrated the functional importance of an endogenous opioid system in cultured corneal epithelial ceUs, it was necessary to determine if OGF and the {-opioid receptor were present. Immunocytochemical stumes revealed that both the OGF and {-receptor were localized to corneal epithelial ceUs. Therefore, not only does OGF have a profound effect on growth, but it appears that this peptide and its receptor are present in these cells. These data are consistent with observations showing the presence and function of OGF and the {-reeeptor in developing neural cells and in epithelial ceUs of the adult mammalian tongue (30, 31, 33). Most importantly, these results are consonant with reports of OGF and the {-reeeptor in the cornea of a wide variety of vertebrates (32l.
OGF immunoreactivity was found in outgrowths from explants growing in serum-free media. Thus it may be hypothesized that in corneal epithelium, as in other systems (27, 28, 30), OGF is an autocrine and/or paracrine growth factor. In fact, OGF has been detected in the bovine corneaI epithelium by reversed phase-high perforn1ance liquid chromatography and radioimmunoassay and by fast atom bombardment-mass spectrometry (18, 19). Moreover, proenkephalin A derivatives, including OGF, have been found in the rat lacrimal gland, suggesting involvement of this opioid peptide with lacrimal seeretion (4). These studies add admtional support that OGF, derived either from autocrine and/or paracrine sourees, is associated with the mammalian cornea.
A number of growth factors and/or receptors, or their mRNAs, have been reported in normal corneal epithelium (6, 7, 10, 15-17, 20, 23-25) . Such substances as epidermal growth factor, acidic fibroblast growth factor, basic fibroblast growth factor, nerve growth factor, hepatocyte growth factor, keratinocyte growth factor, and substance P alter cellular events (e.g., stimulate ceU proliferation l. This study provides the first report of an inhibitory growth factor in the corneal epithelium. Furthern1ore, it is the initial study to demonstrate that the interaction of the opioid peptide, OGF, and the opioid receptor, {, tonically regulate the growth of corneal epithelial cells in vitro. A physiological role for this endogenous opioid system is suggested by our finding that both OGF and the {-receptor are present in the normal corneal epithelium. Further work is needed to in\"estigate v·;hether opioid peptides also function in the cornea in \ivo. The knowledge that the opioid system is functional in vivo could be significant to our understanding of normal corneal epithelial homeostasis and wound healing. Abnormalities in this opioid system could be hypothesized to contribute to various disease processes. Conversely, the enhancement or manipulation of this endogenous opioid system might prove beneficial in accelerating the healing of wounds and in the maintenance of corneal integrity.
